Effective as of November, the EAN Board decided to create a new Neuroscience/translational Scientific Panel.

Dear Prof. McNicholas, thank you for accepting this interview. In light of the work towards an MoU with EAN, we would like to introduce the ESRS to the EANpages readers.

First of all, I would like to wish you a very happy holiday season and every success in the New Year! As we approach the end of 2019, we can look back on another highly productive year for EAN with yet another successful congress. The number of delegates was an all-time high and we can boast on eminent keynote speakers, and well-attended scientific sessions and teaching courses. As our main mission is to promote excellence in neurology across Europe, we aim to continue this success and hard work into the future. With that in mind, I would like to tell you a little about some recent changes and plans that EAN has in order to support this important mission to the benefit of neurologists and patients throughout Europe.

For December 2019, we have selected: Cree et al., Inebilizumab for the treatment of neuromyelitis optica (N-MOmentum): a double-blind, randomised placebo-controlled  phase 2/3 trial Lancet 2019 Epub ahead of print Sept 5.

Armenia is located in the South Caucasus, bordered by Georgia from the north, Iran from the South, Azerbaijan from the north-east and the south-west and Turkey from the west. The Republic of Armenia occupies a territory of 29,800 square kilometres. The capital is Yerevan. According to the general census of 2011 the population of Armenia is 3,018,854, 1.1 million of whom live in Yerevan.

Findings suggest narcolepsy type 1 to be a T-cell mediated autoimmune disease targeting hypocretin-producing neurons.

Nakalanga syndrome: Clinical characteristics, potential causes, and its relationship with recently described Nodding syndrome

President Prof Fazekas continues to recover.

ERN-RND provides educational webinars on rare neurological and neuromuscular diseases - in collaboration with the European Reference Network for Rare Neuromuscular Diseases (EURO-NMD) and the European Academy of Neurology (EAN).

New treatment options for pediatric convulsive status epilepticus after failure of first-line benzodiazepines

On October 12-15, the Italian society of neurology (SIN, Società Italiana di Neurologia) celebrated its 50th congress in Bologna. Bologna has the oldest Italian University, founded in 1088, and is the town of many outstanding Italian neuroscientists. Moreover, Bologna has been the nest of some of the major European schools in the field of epilepsy and sleep medicine.

During the last meeting of the Board, it has been decided that the current Rare neurological diseases task force, founded in 2016, will be transformed into the first EAN Coordinating Panel.

Summer 2019 Newsletter from European Partnership on Competencies for High Value COst COnscious CARE Project

In order to give our members a deeper insight into the work of EAN’s Scientific Panels, EANpages will feature a different Scientific Panel each month along with a video interview with its co-chairs, explaining the Scientific Panel’s focus, it’s aims and achievements. For November, you can watch a video interview with Marie Vidailhet, Chair of the EAN Scientific Committee where she introduces the Scientific Panels and their important role.

In this article, we present an overview of this year’s European Congress of Neurorehabilitation, organized in the beautiful city of Budapest between 9-12 October 2019, hosted by one of our closest partners - the European Federation of Neurorehabilitation Societies (EFNR). The EFNR is an international organization dedicated to research, education, intellectual and scientific exchange, advocacy, and philanthropic activities in the field of neurorehabilitation medicine and related professional areas of expertise.